[1]李亚,李春梅,陈茜.加味小青龙汤联合沙美特罗替卡松治疗支气管哮喘疗效观察[J].西部中医药,2020,33(04):103-105.[doi:10.12174/j.issn.1004-6852.2020.04.31]
 LI Ya,LI Chunmei,CHEN Qian.Clinical Observation on Modified XiaoQinglong Tang Joined with Salmeterol Fluticasone in Treating Bronchial Asthma[J].Western Journal of Traditional Chinese Medicine,2020,33(04):103-105.[doi:10.12174/j.issn.1004-6852.2020.04.31]
点击复制

加味小青龙汤联合沙美特罗替卡松治疗支气管哮喘疗效观察
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
33
期数:
2020年04期
页码:
103-105
栏目:
报道·衷中参西
出版日期:
2020-04-15

文章信息/Info

Title:
Clinical Observation on Modified XiaoQinglong Tang Joined with Salmeterol Fluticasone in Treating Bronchial Asthma
文章编号:
1004-6852(2020)04-0103-03
作者:
李亚李春梅陈茜
1 西安市高陵区医院,陕西 西安 710200; 2 空军军医大学唐都医院; 3 镇安县人民医院
Author(s):
LI Ya1 LI Chunmei2 CHEN Qian3△
1 Xi′an City Gaoling District Hospital, Xi′an 710200, China; 2 The Forth Medical University Tangdu Hospital;3 Zhen′an County People′s Hospital
关键词:
支气管哮喘小青龙汤沙美特罗替卡松日间哮喘症状评分
Keywords:
bronchial asthma XiaoQinglong Tang salmeterol fluticasone daytime asthma symptom scores
分类号:
R562.2+5
DOI:
10.12174/j.issn.1004-6852.2020.04.31
文献标志码:
B
摘要:
目的:观察加味小青龙汤联合沙美特罗替卡松治疗支气管哮喘的临床效果。方法:将147例患者按照就诊顺序分为观察组(72例)和对照组(75例),给予两组患者止咳化痰、抗感染、吸氧等基础治疗。对照组给予患者沙美特罗替卡松进行治疗,观察组在此基础上给予加味小青龙汤进行治疗。治疗2周后,观察两组患者临床疗效及临床症状、体征消失时间、治疗前后日间哮喘症状评分及生活质量评分的变化情况。结果:有效率观察组为91.7%(66/72),对照组为76.0%(57/75),两组比较差异有统计学意义(P<0.05)。止咳时间、肺啰音消失时间、气喘消失时间、哮鸣音消失时间两组比较差异有统计学意义(P<0.05)。日间哮喘症状评分及生活质量评分治疗前两组比较,差异无统计学意义(P>0.05);治疗前后两组组内比较,差异有统计学意义(P<0.05);治疗后两组组间比较,差异也有统计学意义(P<0.05)。结论:加味小青龙汤联合沙美特罗替卡松治疗支气管哮喘的效果显著,可有效缩短患者的临床症状及体征消失时间,同时缓解其日间哮喘症状,提升生活质量。
Abstract:
Objective: To observe clinical effects of modified XiaoQinglong Tang joined with salmeterol fluticasone in treating bronchial asthma. Methods: A total of 147 patients were separated into the the observation group (72 cases) and the control group (75 cases) according to random number table method, both groups accepted basic therapy of stopping cough, removing phlegm, anti-inflammation, oxygen inhalation and others. The control group were treated by salmeterol fluticasone, and the observation group took modified XiaoQinglong Tang based on the therapy that the control group accepted, to compare clinical effects, clinical symptoms, the disappearing time of body signs, the changes of daytime asthma symptom scores and quality of life scores before and after treating. Results: The effective rate of the observation group was 91.7% (66/72), higher than 76.0% (57/75) of the control group, and the difference had statistical meaning (P<0.05). The difference showed statistical meaning in cough-stoping time, lung rales disappearing time, asthma disappearing time and disappearing time of wheezing rale between both groups (P<0.05). The difference had no statistical meaning in daytime asthma symptom score and the scores of quality of life between both groups before treating (P>0.05); the difference was statistically significant within both groups before and after treating (P<0.05); the difference showed statistical meaning between both groups after treating (P<0.05). Conclusion: Modified XiaoQinglong Tang joined with salmeterol fluticasone could obtain nobtable effects in treating bronchial asthma, it could effectively shorten disappearing time of clinical symptoms and body signs, simultaneously relieve daytime asthma symptoms and lift quality of life.

相似文献/References:

[1]向建华,毛良平,韩鹏凯,等.沙美特罗替卡松联合金水宝胶囊治疗中度非急性发作期支气管哮喘100例临床观察*[J].西部中医药,2013,26(05):97.
 XIANG Jianhua,MAO Liangping,HAN Pengkai,et al.Observation on Salmeterol Fluticasone Combined with JinShuiBao Capsule for 100 Cases of Moderate Bronchial Asthma during the Period of Non Acute Attack[J].Western Journal of Traditional Chinese Medicine,2013,26(04):97.
[2]王富国,张之舜,丁芬.中西医结合治疗慢性阻塞性肺疾病急性加重期28例疗效观察[J].西部中医药,2012,25(09):70.
 WANG Fu-guo,ZHANG Zhi-shun,DING Fen.Treating 28 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation with Integrated Traditional Chinese and Western Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(04):70.
[3]玛丽亚,孙学健,严兴海.新疆昌吉地区238例支气管哮喘发作期患者中医证型分布[J].西部中医药,2013,26(12):63.
 MA Liya,SUN Xuejian,YAN Xinghai.TCM Patterns Distribution of 238 Cases of Bronchial Asthma at Exacerbation Stage in Changji of XinJiang[J].Western Journal of Traditional Chinese Medicine,2013,26(04):63.
[4]王盛强.中西医结合治疗发作期支气管哮喘48例[J].西部中医药,2014,27(02):110.
 WANG Shengqiang.Treating 48 Cases of Bronchial Asthma at Attack Stage by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(04):110.
[5]吴大斌.益气固本汤合俞募配穴敷贴治疗支气管哮喘45例[J].西部中医药,2014,27(10):127.
[6]张晔敏.川芎平喘合剂治疗慢性持续期支气管哮喘74例[J].西部中医药,2014,27(12):64.
[7]祝伟,田浩.川芎嗪联合小剂量雷公藤治疗儿童哮喘急性发作期患儿38例[J].西部中医药,2015,28(02):102.
[8]贾红光,罗永伟,陈超,等.对支气管哮喘患者电话随访式健康教育的效果评价[J].西部中医药,2015,28(12):115.
[9]张坤,秦慧娟,陈桂花△.基于中医体质的健康管理对支气管哮喘患者远期疗效的影响[J].西部中医药,2019,32(04):123.
 ZHANG Kun,QIN Huijuan,CHEN Guihua.Effects of Health Management on Long-term Outcomes of the Patients with Bronchial Asthma Based on TCM Constitution[J].Western Journal of Traditional Chinese Medicine,2019,32(04):123.
[10]李素娟 彭万胜 陈开泉.基于行为转变理论对支气管哮喘患儿开展延续性护理的效果观察[J].西部中医药,2020,33(S1):94.
 Li Sujuan Peng Wansheng Chen Kaiquan.Observation on the Effects of Carrying out Continuous Care for Children with Bronchial Asthma Based on Trans-theoretical Model[J].Western Journal of Traditional Chinese Medicine,2020,33(04):94.

备注/Memo

备注/Memo:
收稿日期:2019-07-02*基金项目:国家级公益性行业科研专项(201402024)。作者简介:李亚(1974—),女,硕士学位,副主任医师。研究方向:慢性阻塞性肺疾病,哮喘,社区获得性肺炎的诊治。△通讯作者:陈茜(1975—),女,副主任医师。研究方向:慢性阻塞性肺疾病,慢性呼吸衰竭,肺间质疾病的诊治。
更新日期/Last Update: 2020-04-15